Drugs / VRON-0200-AdC6
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06070051 | Sep 2023 → Mar 2026 overdue | chronic hepatitis B virus infection | Virion Therapeutics | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VRON-0200-AdC6 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06070051 ↗ |
| Modality | Vaccine | “VRON-0200 chimpanzee adenovirus serotype 6 vaccine vector” NCT06070051 ↗ |
| Route | Intramuscular | “VRON-0200 vaccine doses will be administered by intramuscular (IM) injection” NCT06070051 ↗ |